Skip to Main Navigation

GUINEA COVID-19 PREPAREDNESS AND RESPONSE PROJECT

Abstract*

The proposed project will support the implementation of the Guinea COVID-19 Plan.

* The project abstract is drawn from the PAD, SAR or PGD and may not accurately reflect the project's current nature

Show More

Development Objective

To prevent, detect and respond to the threat posed by COVID-19 and strengthen national systems for public health preparedness in Guinea.

Key Details

Project Details

  • P174032

  • Closed

  • Zenab Konkobo Kouanda , Teegwende Porgo

  • Republic of Guinea

  • Guinea

  • June 1, 2020

  • (as of board presentation)

    June 17, 2020

  • July 28, 2020

  • US$ 39.10 million

  • Ministry of Health (Ministère de la Santé)

  • Western and Central Africa

  • 2020

  • US$ 39.10 million

  • N/A

  • Substantial

  • June 30, 2024

  • No

  • BANK APPROVED

  • June 24, 2024

  • Notes

Finances

Financing Plan (US$ Millions)

No data available.
Financier Commitments
IDA Credit 19.55
IDA Grant 19.55

Total Project Financing (US$ Millions)

Product Line IBRD/IDA
IBRD Commitment N/A
IDA Commitment 39.10
IBRD + IDA Commitment 39.10
Lending Instrument
Grant Amount N/A
Total Project Cost** 39.10

Summary Status of World Bank Financing (US$ Millions) as of March 31, 2025

Download:
No data available.
Financier Approval Date Closing Date Principal Disbursed Repayments Interest, Charges & Fees

Detailed Financial Activity as of March 31, 2025

Download:
No data available.
Period Financier Transaction Type Amount (US$)
Apr 25, 2024 IDA-71910 Loan Cancel 12,520,620.00
Apr 25, 2024 IDA-E1080 Loan Cancel 12,520,620.00
Jan 29, 2024 IDA-D8940 Loan Disb 386,510.44
Jun 26, 2023 IDA-D8940 Loan Disb 218,606.58
Dec 15, 2023 IDA-67350 Int Charges 354.45
Dec 15, 2023 IDA-67350 Int Charges 354.45
Oct 18, 2023 IDA-69700 Int Charges 354.27
Oct 18, 2023 IDA-69700 Int Charges 354.27
Oct 18, 2023 IDA-69700 Int Charges 12,825.37
Oct 18, 2023 IDA-69700 Int Charges 12,825.37
Nov 7, 2023 IDA-D8940 Loan Disb 460,002.25
Nov 30, 2023 IDA-D8940 Loan Disb 223,538.83
Jan 8, 2024 IDA-67350 Int Charges 17,838.81
Jan 8, 2024 IDA-67350 Int Charges 17,838.81
Apr 4, 2023 IDA-69700 Loan Disb 1,313,979.10
Jun 1, 2023 IDA-D8940 Loan Disb 600,000.00
Mar 5, 2021 IDA-D6870 Loan Disb 1,607,651.40
Mar 12, 2021 IDA-67350 Loan Disb 565,401.44
Dec 30, 2020 IDA-D6870 Loan Disb 1,357,030.00
Mar 10, 2021 IDA-67350 Loan Disb 479,456.70
Sep 21, 2020 IDA-D6870 Loan Disb 1,000,000.00
Feb 23, 2021 IDA-D6870 Loan Disb 920,349.75
Jan 14, 2021 IDA-D6870 Loan Disb 357,855.70
Jan 11, 2021 IDA-D6870 Loan Disb 488,973.28
Mar 9, 2021 IDA-67350 Loan Disb 740,624.75
Jun 16, 2021 IDA-67350 Int Charges 5,378.29
Jun 16, 2021 IDA-67350 Int Charges 5,378.29
Jun 1, 2021 IDA-67350 Loan Disb 600,000.00
Apr 12, 2021 IDA-67350 Loan Disb 1,406,840.00
Jun 7, 2021 IDA-67350 Loan Disb 1,515,404.10
Jun 17, 2020 IDA-67350 Loan Commitment 5,450,000.00
Jun 17, 2020 IDA-D6870 Loan Commitment 5,450,000.00
Jun 6, 2024 IDA-69700 Loan Disb 3,053,667.00
Jun 29, 2021 IDA-69700 Loan Commitment 14,100,000.00
Jun 29, 2021 IDA-D8940 Loan Commitment 14,100,000.00
Jun 23, 2022 IDA-71910 Loan Commitment 12,715,000.00
Jun 23, 2022 IDA-E1080 Loan Commitment 12,715,000.00
Jun 15, 2024 IDA-67350 Int Charges 18,281.90
Jun 15, 2024 IDA-67350 Int Charges 18,281.90
May 20, 2024 IDA-69700 Loan Disb 1,140,728.10
Jun 28, 2024 IDA-69700 Loan Disb 223,022.70
Jun 7, 2024 IDA-69700 Loan Disb 300,000.00
Apr 8, 2024 IDA-69700 Loan Disb 1,500,000.00
Jun 15, 2024 IDA-67350 Int Charges 359.26
Jun 15, 2024 IDA-67350 Int Charges 359.26
Jun 7, 2024 IDA-69700 Loan Disb 567,304.25
Jun 27, 2024 IDA-69700 Loan Disb 961,176.00
May 23, 2024 IDA-69700 Loan Disb 597,065.56
Apr 15, 2024 IDA-69700 Int Charges 213.09
Apr 15, 2024 IDA-69700 Int Charges 213.09
Apr 15, 2024 IDA-69700 Int Charges 12,906.94
Apr 15, 2024 IDA-69700 Int Charges 12,906.94
Feb 29, 2024 IDA-D8940 Loan Disb 87,113.19
Mar 12, 2024 IDA-69700 Loan Disb 300,000.00
Mar 20, 2024 IDA-69700 Loan Disb 400,000.00
Apr 25, 2024 IDA-69700 Loan Cancel 432,290.88
Jul 3, 2023 IDA-67350 Int Charges 753.88
Jul 3, 2023 IDA-67350 Int Charges 753.88
Jul 3, 2023 IDA-67350 Int Charges 18,473.24
Jul 3, 2023 IDA-67350 Int Charges 18,473.24
Apr 28, 2023 IDA-D6870 Loan Disb -95,389.44
Mar 3, 2023 IDA-D8940 Loan Disb 195,000.02
Apr 13, 2023 IDA-69700 Loan Disb 1,519,732.00
Apr 27, 2023 IDA-69700 Loan Disb 160,323.00
Apr 27, 2023 IDA-69700 Loan Disb 201,397.02
Apr 27, 2023 IDA-69700 Loan Disb 375,881.00
Dec 16, 2021 IDA-67350 Int Charges 19,414.07
Dec 16, 2021 IDA-67350 Int Charges 19,414.07
Dec 16, 2021 IDA-67350 Int Charges 455.02
Dec 16, 2021 IDA-67350 Int Charges 455.02
Jan 28, 2022 IDA-D8940 Loan Disb 1,000,000.00
Dec 15, 2022 IDA-67350 Int Charges 480.28
Dec 15, 2022 IDA-67350 Int Charges 480.28
Dec 15, 2022 IDA-67350 Int Charges 17,248.93
Dec 15, 2022 IDA-67350 Int Charges 17,248.93
Dec 14, 2022 IDA-D8940 Loan Disb 411,640.80
Jun 15, 2022 IDA-67350 Int Charges 18,297.56
Jun 15, 2022 IDA-67350 Int Charges 18,297.56
Jun 15, 2022 IDA-67350 Int Charges 199.99
Jun 15, 2022 IDA-67350 Int Charges 199.99
Apr 12, 2022 IDA-D8940 Loan Disb 9,770,041.00

Footnotes

Ratings

IMPLEMENTATION RATINGS

Name Review Date
Progress towards achievement of PDO Satisfactory 2024-05-10
Procurement Satisfactory 2024-05-10
Monitoring and Evaluation Moderately Satisfactory 2024-05-10
Overall Implementation Progress (IP) Moderately Satisfactory 2024-05-10
Project Management Moderately Satisfactory 2024-05-10
Financial Management Satisfactory 2024-05-10

COMPLETION RATINGS

No data available.

INDEPENDENT EVALUATION RATINGS

No data available.

Results Framework

PROJECT DEVELOPMENT OBJECTIVE INDICATORS

INDICATORBASELINECURRENTTARGET
  • Suspected cases of COVID-19 cases reported and investigated based on national guidelinesValue400.0019143.001000.00
    DateJuly 28, 2020July 31, 2022July 31, 2022
    Comment
  • Designated laboratories with COVID-19 diagnostic equipment, test kits, and reagentsValue4.0012.008.00
    DateJuly 28, 2020July 31, 2022July 31, 2022
    Comment
  • Acute healthcare facilities with isolation capacityValue7.90100.0090.00
    DateJuly 28, 2020July 31, 2022July 31, 2022
    Comment
  • Population fully vaccinated, which is included in the priority population targets defined in the national plan, by genderValue0.0045.0050.00
    DateApril 16, 2021May 5, 2024June 30, 2025
    Comment
  • Women fully vaccinated, which is included in the priority population targets defined in the national planValue0.0047.0050.00
    DateApril 16, 2021May 5, 2024June 30, 2025
    Comment
  • Enta Nord Regional Hospital completed and operationalValueNoNoYes
    DateJune 26, 2023May 5, 2024June 30, 2025
    Comment

INTERMEDIATE RESULTS INDICATORS

INDICATORBASELINECURRENTTARGET
  • M&E system established to monitor COVID-19 preparedness and response planValueNoYesYes
    DateJuly 28, 2020May 5, 2024June 30, 2025
    Comment
  • Health staff trained in infection prevention and control per MOH-approved protocolsValue0.001204.001400.00
    DateJuly 28, 2020May 5, 2024June 30, 2025
    Comment
  • Vaccination sites that transmit their data via DHIS2Value0.00100.00100.00
    DateApril 16, 2021May 5, 2024June 30, 2025
    Comment
  • Designated laboratories with staff trained to conduct COVID-19 diagnosisValue4.0012.008.00
    DateJuly 28, 2020July 31, 2022July 31, 2022
    Comment
  • Number of health facilities including CT-EPI equippedValue0.0033.0030.00
    DateJune 26, 2023May 5, 2024June 30, 2025
    Comment
  • HMIS collecting sex and age disaggregated data on COVID-19 indicators for testing, treatment, and vaccinesValueNoYesYes
    DateApril 16, 2021May 5, 2024June 30, 2025
    Comment
  • Country has prepared guidelines to care for COVID-19 patientsValueNoYesYes
    DateJuly 28, 2020July 31, 2022July 31, 2022
    Comment
  • Number of community health staff trained in community-based surveillanceValue0.000.003000.00
    DateJune 26, 2023May 5, 2024June 30, 2025
    Comment
  • Vaccinators trained on GBV/SEA/SHValue0.000.0095.00
    DateApril 16, 2021May 5, 2024June 30, 2025
    Comment
  • Start-ups recruited for the development of innovative and digital technology solution for accelerated COVID-19 prevention and responseValue0.004.005.00
    DateJuly 28, 2020July 31, 2022July 31, 2022
    Comment
  • Grievances addressed within the time specified in the project implementation manualValue0.00100.0080.00
    DateJuly 28, 2020May 5, 2024June 30, 2025
    Comment
  • Key gender-responsive messages and materials developed for public communications and advocacy, in alignment with demand planValueNoYesYes
    DateApril 16, 2021May 5, 2024June 30, 2025
    Comment
  • Cold rooms fully equippedValue0.000.008.00
    DateApril 16, 2021May 5, 2024June 30, 2025
    Comment
  • Health regions with a functional AEFI monitoring committeeValue0.00100.00100.00
    DateApril 16, 2021May 5, 2024June 30, 2025
    Comment
  • Beneficiaries reporting that community engagement and outreach meet their needsValue0.000.0050.00
    DateApril 16, 2021May 5, 2024June 30, 2025
    Comment
  • Adolescents fully vaccinated, which is included in the priority population targets defined in the national planValue1.4010.0015.00
    DateMay 25, 2022May 5, 2024June 30, 2025
    Comment
  • Population receiving a booster, which is included in the population targets defined in the national planValue0.0030.0030.00
    DateMay 25, 2022May 5, 2024June 30, 2025
    Comment